BridgeBio Pharma
(NASDAQ) BBIO
BridgeBio Pharma Financials at a Glance
Market Cap
$14.43B
Revenue (TTM)
$502.08M
Net Income (TTM)
$729.31M
EPS (TTM)
$-3.78
P/E Ratio
-19.67
Dividend
$0.00
Beta (Volatility)
1.39 (Average)
Dividend
$0.00
Beta (Volatility)
1.39 (Average)
Price
$74.46
Volume
65,386
Open
$75.00
Price
$74.46
Volume
65,386
Open
$75.00
Previous Close
$74.46
Daily Range
$73.43 - $75.66
52-Week Range
$28.32 - $84.94
Dividend
$0.00
Beta (Volatility)
1.39 (Average)
Price
$74.46
Volume
65,386
Open
$75.00
Previous Close
$74.46
Daily Range
$73.43 - $75.66
52-Week Range
$28.32 - $84.94
BBIO News
BBIO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BridgeBio Pharma
Industry
Biotechnology
Sector
Health CareEmployees
839
CEO
Neil Kumar, PhD
Website
www.bridgebio.comHeadquarters
Palo Alto, CA 94301, US
BBIO Financials
Key Financial Metrics (TTM)
Gross Margin
94%
Operating Margin
-1%
Net Income Margin
-1%
Return on Equity
0%
Return on Capital
-88%
Return on Assets
-78%
Earnings Yield
-5.08%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$14.43B
Shares Outstanding
193.86M
Volume
65.39K
Short Interest
0.00%
Avg. Volume
2.86M
Financials (TTM)
Gross Profit
$473.81M
Operating Income
$569.09M
EBITDA
$672.88M
Operating Cash Flow
$445.91M
Capital Expenditure
$1.10M
Free Cash Flow
$447.01M
Cash & ST Invst.
$587.48M
Total Debt
$2.73B
BridgeBio Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$154.18M
+2521.2%
Gross Profit
$138.76M
+3553.6%
Gross Margin
90.00%
N/A
Market Cap
$14.43B
N/A
Market Cap/Employee
$19.91M
N/A
Employees
725
N/A
Net Income
$197.24M
+25.6%
EBITDA
$180.24M
+23.3%
Quarterly Fundamentals
Net Cash
$2.14B
-104.0%
Accounts Receivable
$139.44M
+2853.1%
Inventory
$26.75M
N/A
Long Term Debt
$2.71B
+57.1%
Short Term Debt
$17.41M
+286.4%
Return on Assets
-77.92%
N/A
Return on Invested Capital
-87.81%
N/A
Free Cash Flow
$60.95M
+69.3%
Operating Cash Flow
$56.42M
+71.1%